Prevalence and outcomes of patients taking oral corticosteroids for over 1 month undergoing major surgery in England 2010-2020
- PMID: 39775803
- PMCID: PMC11885188
- DOI: 10.1111/anae.16532
Prevalence and outcomes of patients taking oral corticosteroids for over 1 month undergoing major surgery in England 2010-2020
Abstract
Introduction: Approximately 1% of the UK population is prescribed oral corticosteroids at any one time. It is not known how many of these patients present for major surgery. We aimed to establish the prevalence, characteristics and outcomes of patients taking oral corticosteroids.
Methods: We identified patients aged > 18 y undergoing major surgery between 1 April 2010 and 31 March 2020 from Hospital Episode Statistics with linked Clinical Practice Research Datalink data and the Office for National Statistics Mortality register in England. Prescribing data were used to define three sets of patients: 'low-dose' - taking ≤ 7.5 mg oral prednisolone equivalents per day for at least 28/91 days before surgery; 'high-dose' - taking > 7.5 mg oral prednisolone equivalents per day for at least 28/ 91 days before surgery; and a 'no-steroids' group. We used ≤ 7.5 mg of prednisolone equivalents per day as our threshold, as this would likely exclude almost all patients who were taking corticosteroids as replacement for absolute adrenal/pituitary deficiency.
Results: We identified 1,999,326 adult patients for inclusion in the dataset: 1,929,291 (96.5%) in the no-steroids; 63,353 (3.2%) in the low-dose group; and 6682 (0.3%) in the high-dose group. Median (IQR [range]) duration of hospital stay increased with increasing dose of corticosteroid (no-steroid 3 (0-14 [0-14,739]); low-dose 5 (1-26 [1-8079]); and high-dose 7 (2-28 [0-6956]) days). Mortality after the index surgery was 1.5%, 3.8% and 8.9% at 30 days and 5.5%, 11.6% and 39.9% at 1 year for no-steroids, low-dose and high-dose groups, respectively.
Conclusion: Around 1 in 29 patients undergoing major surgery are taking oral corticosteroids for > 28 days in the 3 months before major surgery. Their outcomes are poor and warrant highlighting within care pathways to aid risk prediction and mitigation.
Keywords: adrenal gland; corticosteroids; glucocorticoids; routinely collected data; surgery.
© 2025 The Author(s). Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists.
Similar articles
-
Peri-operative Replacement of Exogenous Steroids (PREdS): a national audit of current peri-operative prescribing for patients taking therapeutic steroids.Anaesthesia. 2024 Oct;79(10):1042-1052. doi: 10.1111/anae.16388. Epub 2024 Aug 3. Anaesthesia. 2024. PMID: 39096191
-
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.BMJ. 1996 Aug 10;313(7053):344-6. doi: 10.1136/bmj.313.7053.344. BMJ. 1996. PMID: 8760745 Free PMC article.
-
Is enough attention being given to the adverse effects of corticosteroid therapy?J Clin Pharm Ther. 2000 Jun;25(3):227-34. doi: 10.1046/j.1365-2710.2000.00284.x. J Clin Pharm Ther. 2000. PMID: 10886467
-
Prophylactic corticosteroids for cardiopulmonary bypass in adult cardiac surgery.Cochrane Database Syst Rev. 2024 Mar 20;3(3):CD005566. doi: 10.1002/14651858.CD005566.pub4. Cochrane Database Syst Rev. 2024. PMID: 38506343 Free PMC article.
-
Corticosteroids for periorbital and orbital cellulitis.Cochrane Database Syst Rev. 2021 Apr 28;4(4):CD013535. doi: 10.1002/14651858.CD013535.pub2. Cochrane Database Syst Rev. 2021. PMID: 33908631 Free PMC article.
References
-
- Woodcock T, Barker P, Daniel S, et al. Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia 2020; 75: 654–663. 10.1111/anae.1496. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous